Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1782303 · BOLD

Boundless Bio, Inc.

Filing with the SEC SEC-reporting company La Jolla, CA Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • RestructuringOn Jun 23, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).
  • Change in controlOn Jun 23, 2026 the company reported a change in control (Item 5.01).
  • Net loss in 2025Net loss of $58.2M for the year (2024: −$65.4M).

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$58.2M−$65.4M
Total assets$157M$206M
Total liabilities$58.4M$55.8M
Stockholders’ equity$98.7M$151M
Cash and equivalents$17.9M$26.6M

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Boundless Bio, Inc.
CIK
0001782303
Tickers
BOLD
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company
Status
Filing with the SEC
State of incorporation
Delaware
Business address
La Jolla, California
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 10, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 10, 2026 · filing · edition of Nov 10, 2026
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 7, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.05, 3.02, 5.01, 5.02, 7.01, 8.01, 9.01 · filed Jun 23, 2026 · filing
  • Change in control
    Form 8-K · items 1.01, 2.05, 3.02, 5.01, 5.02, 7.01, 8.01, 9.01 · filed Jun 23, 2026 · filing
  • Restructuring or layoffs
    Form 8-K · items 1.01, 2.05, 3.02, 5.01, 5.02, 7.01, 8.01, 9.01 · filed Jun 23, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 8, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 8, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 2.02, 5.02, 9.01 · filed Mar 9, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 5.02, 9.01 · filed Mar 9, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 9, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 5, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 5, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 5, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 5, 2025 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 8.01 · filed May 23, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 9, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 9, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Mar 27, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 27, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 8.01, 9.01 · filed Dec 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 7, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 7, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Oct 29, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Oct 15, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Aug 20, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 12, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 13, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Mar 28, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Mar 6, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Aug 15, 2023 · filing